Tech Company CollectionsBiotechnology Companies
List of Biotechnology Companies
or search all companiesSelect...
Select...
Loading...
Page 1 of NaN
Displaying companies
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven histo | San Francisco | CA | 5 - 10 | 2025 | $120,000,000 |
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lys | San Francisco | CA | 10 - 50 | 2025 | $200,000,000 |
K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots. | New York | NY | 2 - 10 | 2024 | $500,000 |
GEMMABio is a therapeutics company that supports the rare disease community. | Philadelphia | PA | 50 - 100 | 2024 | $34,000,000 |
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 10 - 50 | 2024 | $325,000,000 |
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free f | San Francisco | CA | 2 - 10 | 2024 | $30,000,000 |
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. | 10 - 50 | 2024 | $60,251,248 | ||
Navigator Medicines operate as a biotech company that leads the advancement of biologics for targeted immune regulation & restoration. | Scotch Plains | NJ | 2 - 10 | 2024 | $100,000,000 |
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the str | Boston | MA | 10 - 50 | 2024 | $100,000,000 |
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies. | San Francisco | CA | 10 - 50 | 2024 | $48,000,000 |
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | 10 - 50 | 2024 | $105,000,000 | ||
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 10 - 50 | 2024 | $41,000,000 |
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques. | Boston | MA | 50 - 100 | 2024 | $75,000,000 |
Nura Health is a molecular diagnostics company whose mission is to advance women's health through the development and delivery of novel practice-changing non-invasive tests. We prioritize innovative, evidence-based diagnostic methods enhanced by AI & Machi | Irvine | CA | 5 - 10 | 2024 | $3,000,000 |
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. | Waltham | MA | 10 - 50 | 2024 | $400,000,000 |
Jupiter Endovascular is a medical technology start-up. Its mission is to cover the entire spectrum of cardiovascular illness, seeing compelling potential to reinvent treatments for millions of people. | Menlo Park | CA | 10 - 50 | 2024 | $21,000,000 |
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end | San Francisco | CA | 50 - 100 | 2024 | $1,000,000,000 |
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses. | South San Francisco | CA | 10 - 50 | 2024 | $101,000,000 |
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases. | Knoxville | TN | 1 - 10 | 2024 | $3,000,000 |
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines. | 10 - 50 | 2024 | $93,500,000 | ||
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets. | San Francisco | CA | 2 - 10 | 2024 | $92,000,000 |
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external inve | 10 - 50 | 2024 | $300,000,000 | ||
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on pro | San Diego | CA | 10 - 50 | 2024 | $180,000,000 |
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) spec | Wilmington | DE | 10 - 50 | 2024 | $5,500,000 |
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 5 - 20 | 2024 | $370,000,000 |
ParcelBio is a company that creating a programmable method for safely and precisely delivering mRNA to many cell types in the body. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. | San Francisco | CA | 5 - 10 | 2023 | $500,000 |
Granza Bio is a company that developing cancer therapies based on human body's immune system. | San Francisco | CA | 2 - 10 | 2023 | $7,640,000 |
NeuroBionics is pioneering the future of precision bioelectronic medicine by inventing the next generation of implanted devices that will seamlessly interface with the human body. | Seattle | WA | 2 - 10 | 2023 | $11,000,000 |
Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension. RTN-001 has been evaluated in over 265 subjects across 9 clinical trials. In these stu | Falls Church | VA | 1 - 10 | 2023 | $10,400,000 |
Amplifyer Bio is a biotechnology research company that develops technology of transformative potential for the liquid biopsy field. | Lexington | MA | 1 - 10 | 2023 | $7,078,494 |
Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to- | San Francisco | CA | 20 - 50 | 2023 | $245,000,000 |
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites | Cambridge | MA | 50 - 100 | 2023 | $30,877,444 |
Velorum Therapeutics produces powerful cancer treatments that starve tumors. | South San Francisco | CA | 2 - 10 | 2023 | $500,000 |
Biostate AI develops generative AI that benefit all human health. | Palo Alto | CA | 10 - 50 | 2023 | $16,000,000 |
Junevity is a biotech rewinding complex metabolic disease. Based on 6 years of breakthrough research at UCSF, Junevity's REWIND platform identifies high-level regulators of metabolic disease with known pharmacological pathways. Junevity is advancing multip | 1 - 10 | 2023 | $10,000,000 | ||
Pranax is a software company currently based in Pinehurst, Texas, United States. It has been founded in 2023. | Pinehurst | TX | 1 - 10 | 2023 | $10,000,000 |
Mach5 Therapeutics is a biotechnology company. | Atlanta | GA | 1 - 10 | 2023 | $23,354,508 |
CrossBridge Bio operates as a biotechnology company, innovates ADC therapeutics through stable dual linker payload technology. | 2 - 10 | 2023 | $10,000,000 | ||
EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design. The business predicts protein structures by combining biological data from DNA sequences, gene expression, and epigenetic states, allowing scientists to u | New York | NY | 10 - 50 | 2023 | $142,000,000 |
Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding. Transparency, accountability, and accuracy are essential to what makes us a reliable partner for process and analytical developmen | Gainesville | FL | 20 - 50 | 2023 | $36,000,000 |
About HAPPY POTATO - Perfect Fries ! The world's best Flavored French Fries ! Feel the Flavor with everyone's favorite French fries Products Flavoring Perfect Fries | 2 - 10 | 2023 | $5,575,000 | ||
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors. | American Fork | UT | 2 - 10 | 2023 | $500,000 |
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases. | Lexington | KY | 5 - 10 | 2023 | |
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, | Fremont | CA | 20 - 50 | 2023 | $255,000,000 |
Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials. Sealonix is working on a sealant patch that will provide quick hemostasis for abdominopelvic and orthopedic operations. The PramStat patch | Bedford | MA | 2 - 10 | 2023 | $20,000,000 |
Crop Diagnostix is a biotechnology company that uses RNA sequencing and AI for predictive agriculture. | San Diego | CA | 2 - 10 | 2023 | $3,577,993 |
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors. | Palo Alto | CA | 1 - 10 | 2023 | $6,500,000 |
Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drugs derived from placental tissue and consistently delivers a host of beneficial growth factors with potent anti-inflammatory, tissue-protective, and | Chapel Hill | NC | 2 - 10 | 2023 | $11,000,000 |
Caladan Bio specializes in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions. | New York | NY | 2 - 10 | 2023 | $5,100,000 |
Shinobi Therapeutics focuses on creating hypoimmune CD8αβ iPS-T cells that work with the immune system to treat cancer and other diseases. The company utilizes advanced immune evasion technology to enhance the effectiveness and accessibility of cell therap | South San Francisco | CA | 10 - 50 | 2023 | $178,000,000 |
Peregrine Health is a healthcare company formed by Integrative Life Network (ILN) and Integrative Health Centers. | Nashville | TN | 20 - 50 | 2023 | $13,514,671 |
DANNCE is a deep learning solution to automate behavioral analysis for drug development and disease diagnosis. Our platform takes patient video as input and uses our proprietary 3-D pose tracking and behavioral analysis algorithms to quantify behavior. DA | Boston | MA | 2 - 10 | 2023 | $2,600,000 |
SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services. | Somerville | MA | 1 - 10 | 2023 | $500,000 |
Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. | CA | 1 - 10 | 2023 | $8,700,000 | |
Avenue Biosciences is pioneering the future of biotechnology, with a mission to transform the development of protein biologics for healthcare advancements. Our cutting-edge, high-throughput engineering platform transforms the production of protein biologic | Palo Alto | CA | 10 - 50 | 2023 | $2,500,000 |
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease. | San Francisco | CA | 65 | 2023 | $826,000,000 |
Predicta Biosciences is a precision oncology firm that integrates multiomics and liquid biopsies to create diagnostic tools and therapies. They also have an in-house pipeline for novel immunotherapy targets in pre-clinical stages. | Boston | MA | 2 - 10 | 2023 | $5,200,000 |
Edgewood Oncology is a clinical-stage biotechnology business established to fulfill the potential of BTX-A51 for patients with solid tumors that are genetically specified and hematologic malignancies. Our goal is to create a novel treatment that will prolo | Brookline | MA | 2 - 10 | 2023 | $20,000,000 |
Speeding lifesaving cures with AI-driven design & real-time insights for faster, intuitive clinical development & patient access. | Boston | MA | 2 - 10 | 2023 | $7,000,000 |
Primrose Bio is a biotech company that focuses on discovery, development, and manufacturing of new molecules. innovative therapeutics, vaccines and ingredients to aevance global health. | San Diego | CA | 50 - 100 | 2023 | $14,999,999 |
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies . | Los Angeles | CA | 5 - 20 | 2023 | $30,000,000 |
We are Montara Therapeutics, a San Francisco-based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory | San Francisco | CA | 10 - 50 | 2023 | $28,000,000 |
Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases. | 2 - 10 | 2023 | $15,000,000 | ||
Taxa is a synthetic microbiome company sculpting the skin microbiome using genetic engineering technologies such as CRISPR/spCas9. | San Francisco | CA | 2 - 10 | 2023 | $2,500,000 |
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need. | San Francisco | CA | 20 - 50 | 2022 | $87,000,000 |
Keylika developed a platform synthesis technology for mixed ligand metal complexes that is used to generate a multitude of organometallic drugs for treating a wide range of therapeutic conditions: hematology, pain and inflammation, metabolic disorders to i | Walnut Creek | CA | 2 - 10 | 2022 | |
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023. | San Francisco | CA | 196 | 2022 | $652,000,000 |
Serinus Biosciences develops technologies to understand how chemicals work inside malignant tumor cells. They are developing a new generation of AI for drug development by leveraging knowledge-primed models and cancer biology. Their technique makes it poss | New York | NY | 2 - 10 | 2022 | $500,000 |
Guardian Bio is centred on developing a personalised cell therapy based on dendritic cells. | Boston | MA | 2 - 10 | 2022 | $500,000 |
CorriXR Therapeutics is a biotechnology company. The company is headquartered in Wilmington, Delaware, United States. | Wilmington | DE | 5 - 10 | 2022 | $6,525,179 |
Signatur Biosciences is a biotech company that offers bringing molecular diagnostics services for cancer patients. | New York | NY | 5 - 10 | 2022 | $7,500,000 |
Eugit Therapeutics is a therapeutics company that is working to create immunotherapies for the treatment of prostate, ovarian, and breast malignancies. Their gene engineering strategy begins with gamma delta T cells taken from healthy donors and develops a | San Carlos | CA | 2 - 10 | 2022 | $500,000 |
Via Scientific to help scientists and bioinformaticians generate novel science that improves the world. It was founded in 2022. | Cambridge | MA | 20 - 50 | 2022 | $5,000,000 |
Many diseases, including cancer and monogenic diseases, are often caused by specific proteins that are abnormally degraded and lost from the cell. In cancer, protective tumor suppressors are aberrantly destroyed, allowing cancer cells to circumvent cell de | San Francisco | CA | 20 - 50 | 2022 | $65,000,000 |
Vetmab Biosciences is a veterinary company that currently operates in stealth mode. | San Francisco | CA | 2 - 10 | 2022 | $2,000,000 |
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments against age-old threats to human health: high-consequence viral pathogens. | College Park | GA | 5 - 20 | 2022 | $35,000,000 |
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics. | Cambridge | MA | 20 - 50 | 2022 | $75,000,000 |
TorMagnus Pharmaceuticals combines graph theory and network medicine approaches to use AI to aid in the identification of novel drug treatments. The immediate focus is on identifying targets for Parkinson's disease. | San Francisco | CA | 2 - 10 | 2022 | $500,000 |
Eascra Biotech creates Janus base nanomaterials based on DNA nanotechnology that are highly effective and super biocompatible for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions. Its three generations of DN | Boston | MA | 2 - 10 | 2022 | $2,174,990 |
Mekanistic Therapeutics focuse on the development of cancer therapeutics. | Ann Arbor | MI | 5 - 10 | 2022 | $30,000,000 |
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders. | San Francisco | CA | 20 - 50 | 2022 | $94,000,000 |
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases. | Seattle | WA | 5 - 20 | 2022 | $71,000,000 |
Forward Therapeutics is a biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders. Forward Therapeutics is advancing a pipeline of novel, next-generation small molecule immune therapies. | Palm Beach Gardens | FL | 2 - 10 | 2022 | $50,000,000 |
Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding, communication, teamwork, an | Boston | MA | 50 - 100 | 2022 | $250,000,000 |
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma. | Chapel Hill | NC | 10 - 50 | 2022 | $425,000,000 |
Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system. | San Francisco | CA | 5 - 20 | 2022 | $12,000,000 |
Glen Clova Scientific is a company that developing a new gneration of active biological drugs. | Scotland | IN | 2 - 10 | 2022 | 4000000 GBP |
Maverick BioMetals is a biotechnology business that is working to improve lithium processing. Founded in 2022 and is based in San Francisco, CA. | San Francisco | CA | 5 - 10 | 2022 | $10,143,534 |
Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries | Cambridge | MA | 2 - 10 | 2022 | $6,999,999 |
Developing extended-release PLG drug formulations takes $10M+ and 5-10 years. We enable drug manufacturers and CROs to shorten formulation discovery time by 30-50% by utilizing our automation and machine learning platform. | Woodland | CA | 5 - 20 | 2022 | $16,500,000 |
Visiox is a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options. | Tarrytown | NY | 2 - 10 | 2022 | $7,000,000 |
Cell BioEngines, Inc., is a clinical-stage biotech company focused on curing cancer by developing ”off-the-shelf” allogenic cell therapies. The company leverages its proprietary Stem-SPACE platform technology to produce clinical grade cells at scale. | New York | NY | 2 - 10 | 2022 | $1,375,000 |
Uniquity Bio operates as a drug development company. | Malvern | PA | 10 - 50 | 2022 | $300,000,000 |
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. | Cambridge | MA | 20 - 100 | 2022 | $270,000,000 |
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is | Cambridge | MA | 20 - 50 | 2022 | $70,000,000 |
Form Bio is a biotech company that provides solutions to address the data, computational, and technical hurdles in the life sciences. Founded in 2022, the company is based in Austin, Texas, United States. | Austin | TX | 20 - 50 | 2022 | $60,000,000 |
Network Bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases. Its platform delivers a centralized repository for clinical and molecular data that allows researchers to identify patterns and correlati | New York | NY | 10 - 50 | 2022 | $19,500,000 |
OverT Bio operates as a biotech company that provide cell therapy for cancers.. The company's cell therapies identify and develop novel genetic modifications that will help immune cells overcome barriers created by tumors and lead to effective and durable | New York | NY | 2 - 10 | 2022 | $16,120,000 |
Loading...
Everything You Need, One Platform.
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Stay Ahead of the Curve
Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.